Activated NKT Cells can condition different splenic dendritic cell subsets to respond more effectively to TLR engagement and enhance cross-priming

Journal of Immunology

Volumn 195, Issue 3, 2015, Pages 821-831

  Osmond, Taryn L ^a,b   Farrand, Kathryn J ^a   Painter, Gavin F ^b   Ruedl, Christiane ^c   Petersen, Troels R ^a   Hermans, Ian F ^a,b  

^a MALAGHAN INSTITUTE OF MEDICAL RESEARCH   (New Zealand)

^b VICTORIA UNIVERSITY OF WELLINGTON   (New Zealand)

^c NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; ALPHA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 12P40; INTERLEUKIN 12P70; LANGERIN; OVALBUMIN; RESIQUIMOD; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR ALPHA; CD207 PROTEIN, MOUSE; LECTIN; MANNOSE BINDING LECTIN; MEMBRANE ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD8+ T LYMPHOCYTE; CELL DEATH; CELL FUNCTION; CELL INTERACTION; CELL POPULATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; CROSS PRESENTATION; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOKINE STORM; DENDRITIC CELL; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; T CELL DEPLETION; T CELL LYMPHOMA; T LYMPHOCYTE ACTIVATION; TUMOR IMMUNITY; ANIMAL; ANTIGEN PRESENTATION; BIOSYNTHESIS; C57BL MOUSE; GENETICS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; SPLEEN; TRANSGENIC MOUSE;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, SURFACE; CD8-POSITIVE T-LYMPHOCYTES; CROSS-PRIMING; DENDRITIC CELLS; INTERFERON-ALPHA; INTERLEUKIN-12; LECTINS, C-TYPE; LYMPHOCYTE ACTIVATION; MANNOSE-BINDING LECTINS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NATURAL KILLER T-CELLS; SPLEEN; TOLL-LIKE RECEPTORS;

EID: 84937702948     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1401751     Document Type: Article

References (62)

1. den Haan, J. M., S. M. Lehar, and M. J. Bevan. 2000. CD8(+) but not CD8(-) dendritic cells cross-prime cytotoxic T cells in vivo. J. Exp. Med. 192: 1685-1696.
2. Schulz, O., and C. Reis e Sousa. 2002. Cross-presentation of cell-Associated antigens by CD8a+ dendritic cells is attributable to their ability to internalize dead cells. Immunology 107: 183-189.
3. Iyoda, T., S. Shimoyama, K. Liu, Y. Omatsu, Y. Akiyama, Y. Maeda, K. Takahara, R. M. Steinman, and K. Inaba. 2002. The CD8+ dendritic cell subset selectively endocytoses dying cells in culture and in vivo. J. Exp. Med. 195: 1289-1302.
4. Dudziak, D., A. O. Kamphorst, G. F. Heidkamp, V. R. Buchholz, C. Trumpfheller, S. Yamazaki, C. Cheong, K. Liu, H.-W. Lee, C. G. Park, et al. 2007. Differential antigen processing by dendritic cell subsets in vivo. Science 315: 107-111.
5. Iwasaki, A., and R. Medzhitov. 2004. Toll-like receptor control of the adaptive immune responses. Nat. Immunol. 5: 987-995.
6. Edwards, A. D., S. S. Diebold, E. M. Slack, H. Tomizawa, H. Hemmi, T. Kaisho, S. Akira, and C. Reis e Sousa. 2003. Toll-like receptor expression in murine DC subsets: lack of TLR7 expression by CD8 a+ DC correlates with unresponsiveness to imidazoquinolines. Eur. J. Immunol. 33: 827-833.
7. Barral, P., M. D. Sánchez-Niño, N. van Rooijen, V. Cerundolo, and F. D. Batista. 2012. The location of splenic NKT cells favours their rapid activation by bloodborne antigen. EMBO J. 31: 2378-2390.
8. Kinjo, Y., P. Illarionov, J. L. Vela, B. Pei, E. Girardi, X. Li, Y. Li, M. Imamura, Y. Kaneko, A. Okawara, et al. 2011. Invariant natural killer T cells recognize glycolipids from pathogenic Gram-positive bacteria. Nat. Immunol. 12: 966-974.
9. Wu, D., G.-W. Xing, M. A. Poles, A. Horowitz, Y. Kinjo, B. Sullivan, V. Bodmer-Narkevitch, O. Plettenburg, M. Kronenberg, M. Tsuji, et al. 2005. Bacterial glycolipids and analogs as antigens for CD1d-restricted NKT cells. Proc. Natl. Acad. Sci. USA 102: 1351-1356.
10. Wieland Brown, L. C., C. Penaranda, P. C. Kashyap, B. B. Williams, J. Clardy, M. Kronenberg, J. L. Sonnenburg, L. E. Comstock, J. A. Bluestone, and M. A. Fischbach. 2013. Production of a-galactosylceramide by a prominent member of the human gut microbiota. PLoS Biol. 11: e1001610.
11. Kain, L., B. Webb, B. L. Anderson, S. Deng, M. Holt, A. Costanzo, M. Zhao, K. Self, A. Teyton, C. Everett, et al. 2014. The identification of the endogenous ligands of natural killer T cells reveals the presence of mammalian a-linked glycosylceramides. Immunity 41: 543-554.
12. King, I. L., E. Amiel, M. Tighe, K. Mohrs, N. Veerapen, G. Besra, M. Mohrs, and E. A. Leadbetter. 2013. The mechanism of splenic invariant NKT cell activation dictates localization in vivo. J. Immunol. 191: 572-582.
13. Kitamura, H., K. Iwakabe, T. Yahata, S. Nishimura, A. Ohta, Y. Ohmi, M. Sato, K. Takeda, K. Okumura, L. Van Kaer, et al. 1999. The natural killer T (NKT) cell ligand a-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells. J. Exp. Med. 189: 1121-1128.
14. Hermans, I. F., J. D. Silk, U. Gileadi, S. H. Masri, D. Shepherd, K. J. Farrand, M. Salio, and V. Cerundolo. 2007. Dendritic cell function can be modulated through cooperative actions of TLR ligands and invariant NKT cells. J. Immunol. 178: 2721-2729.
15. Clarke, S. R., M. Barnden, C. Kurts, F. R. Carbone, J. F. Miller, and W. R. Heath. 2000. Characterization of the ovalbumin-specific TCR transgenic line OT-I: MHC elements for positive and negative selection. Immunol. Cell Biol. 78: 110-117.
16. Kissenpfennig, A., S. Henri, B. Dubois, C. Laplace-Builhé, P. Perrin, N. Romani, C. H. Tripp, P. Douillard, L. Leserman, D. Kaiserlian, et al. 2005. Dynamics and function of Langerhans cells in vivo: dermal dendritic cells colonize lymph node areas distinct from slower migrating Langerhans cells. Immunity 22: 643-654.
17. Piva, L., P. Tetlak, C. Claser, K. Karjalainen, L. Renia, and C. Ruedl. 2012. Cutting edge: Clec9A+ dendritic cells mediate the development of experimental cerebral malaria. J. Immunol. 189: 1128-1132.
18. Prendergast, K. A., T. L. Osmond, S. Ochiai, I. F. Hermans, and J. R. Kirman. 2014. Sustained in vivo depletion of splenic langerin(+) CD8a(+) dendritic cells is well-tolerated by lang-DTREGFP mice. J. Immunol. Methods 406: 104-109.
19. Reeves, J. P., P. A. Reeves, and L. T. Chin. 2001. Survival surgery: removal of the spleen or thymus. Curr. Protoc. Immunol. Chapter 1: Unit 1.10.
20. Du, W., and J. Gervay-Hague. 2005. Efficient synthesis of alpha-galactosyl ceramide analogues using glycosyl iodide donors. Org. Lett. 7: 2063-2065.
21. Lee, A., K. J. Farrand, N. Dickgreber, C. M. Hayman, S. Jürs, I. F. Hermans, and G. F. Painter. 2006. Novel synthesis of alpha-galactosyl-ceramides and confirmation of their powerful NKT cell agonist activity. Carbohydr. Res. 341: 2785-2798.
22. Giaccone, G., C. J. Punt, Y. Ando, R. Ruijter, N. Nishi, M. Peters, B. M. von Blomberg, R. J. Scheper, H. J. van der Vliet, A. J. van den Eertwegh, et al. 2002. A phase I study of the natural killer T-cell ligand alpha-galactosylceramide (KRN7000) in patients with solid tumors. Clin. Cancer Res. 8: 3702-3709.
23. Moore, M. W., F. R. Carbone, and M. J. Bevan. 1988. Introduction of soluble protein into the class I pathway of antigen processing and presentation. Cell 54: 777-785.
24. Mebius, R. E., and G. Kraal. 2005. Structure and function of the spleen. Nat. Rev. Immunol. 5: 606-616.
25. Qiu, C.-H., Y. Miyake, H. Kaise, H. Kitamura, O. Ohara, and M. Tanaka. 2009. Novel subset of CD8a+ dendritic cells localized in the marginal zone is responsible for tolerance to cell-Associated antigens. J. Immunol. 182: 4127-4136.
26. Idoyaga, J., N. Suda, K. Suda, C. G. Park, and R. M. Steinman. 2009. Antibody to Langerin/CD207 localizes large numbers of CD8a+ dendritic cells to the marginal zone of mouse spleen. Proc. Natl. Acad. Sci. USA 106: 1524-1529.
27. Farrand, K. J., N. Dickgreber, P. Stoitzner, F. Ronchese, T. R. Petersen, and I. F. Hermans. 2009. Langerin+ CD8a+ dendritic cells are critical for crosspriming and IL-12 production in response to systemic antigens. J. Immunol. 183: 7732-7742.
28. Fujii, S., K. Shimizu, C. Smith, L. Bonifaz, and R. M. Steinman. 2003. Activation of natural killer T cells by alpha-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein. J. Exp. Med. 198: 267-279.
29. Hermans, I. F., J. D. Silk, U. Gileadi, M. Salio, B. Mathew, G. Ritter, R. Schmidt, A. L. Harris, L. Old, and V. Cerundolo. 2003. NKT cells enhance CD4+ and CD8+ T cell responses to soluble antigen in vivo through direct interaction with dendritic cells. J. Immunol. 171: 5140-5147.
30. Ataera, H., E. Hyde, K. M. Price, P. Stoitzner, and F. Ronchese. 2011. Murine melanoma-infiltrating dendritic cells are defective in antigen presenting function regardless of the presence of CD4CD25 regulatory T cells. PLoS ONE 6: e17515.
31. Simkins, H. M., E. Hyde, K. J. Farrand, M. L. Ong, M. A. Degli-Esposti, I. F. Hermans, and F. Ronchese. 2011. Administration of a-galactosylceramide impairs the survival of dendritic cell subpopulations in vivo. J. Leukoc. Biol. 89: 753-762.
32. Wilson, N. S., G. M. Behrens, R. J. Lundie, C. M. Smith, J. Waithman, L. Young, S. P. Forehan, A. Mount, R. J. Steptoe, K. D. Shortman, et al. 2006. Systemic activation of dendritic cells by Toll-like receptor ligands or malaria infection impairs cross-presentation and antiviral immunity. Nat. Immunol. 7: 165-172.
33. Shimizu, K., M. Asakura, J. Shinga, Y. Sato, S. Kitahara, K. Hoshino, T. Kaisho, S. P. Schoenberger, T. Ezaki, and S. Fujii. 2013. Invariant NKT cells induce plasmacytoid dendritic cell (DC) cross-talk with conventional DCs for efficient memory CD8+ T cell induction. J. Immunol. 190: 5609-5619.
34. Diana, J., T. Griseri, S. Lagaye, L. Beaudoin, E. Autrusseau, A.-S. Gautron, C. Tomkiewicz, A. Herbelin, R. Barouki, M. von Herrath, et al. 2009. NKT cellplasmacytoid dendritic cell cooperation via OX40 controls viral infection in a tissue-specific manner. Immunity 30: 289-299.
35. Asselin-Paturel, C., G. Brizard, K. Chemin, A. Boonstra, A. O'Garra, A. Vicari, and G. Trinchieri. 2005. Type I interferon dependence of plasmacytoid dendritic cell activation and migration. J. Exp. Med. 201: 1157-1167.
36. Longman, R. S., D. Braun, S. Pellegrini, C. M. Rice, R. B. Darnell, and M. L. Albert. 2007. Dendritic-cell maturation alters intracellular signaling networks, enabling differential effects of IFN-A/b on antigen cross-presentation. Blood 109: 1113-1122.
37. Kinjo, Y., D. Wu, G. Kim, G.-W. Xing, M. A. Poles, D. D. Ho, M. Tsuji, K. Kawahara, C.-H. Wong, and M. Kronenberg. 2005. Recognition of bacterial glycosphingolipids by natural killer T cells. Nature 434: 520-525.
38. Mattner, J., K. L. Debord, N. Ismail, R. D. Goff, C. Cantu, III, D. Zhou, P. Saint-Mezard, V. Wang, Y. Gao, N. Yin, et al. 2005. Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature 434: 525-529.
39. Hotta, C., H. Fujimaki, M. Yoshinari, M. Nakazawa, and M. Minami. 2006. The delivery of an antigen from the endocytic compartment into the cytosol for crosspresentation is restricted to early immature dendritic cells. Immunology 117: 97-107.
40. Weck, M. M., F. Grünebach, D. Werth, C. Sinzger, A. Bringmann, and P. Brossart. 2007. TLR ligands differentially affect uptake and presentation of cellular antigens. Blood 109: 3890-3894.
41. Nishimura, T., H. Kitamura, K. Iwakabe, T. Yahata, A. Ohta, M. Sato, K. Takeda, K. Okumura, L. Van Kaer, T. Kawano, et al. 2000. The interface between innate and acquired immunity: glycolipid antigen presentation by CD1d-expressing dendritic cells to NKT cells induces the differentiation of antigen-specific cytotoxic T lymphocytes. Int. Immunol. 12: 987-994.
42. Carnaud, C., D. Lee, O. Donnars, S. H. Park, A. Beavis, Y. Koezuka, and A. Bendelac. 1999. Cutting edge: Cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells. J. Immunol. 163: 4647-4650.
43. Bar-On, L., T. Birnberg, K. L. Lewis, B. T. Edelson, D. Bruder, K. Hildner, J. Buer, K. M. Murphy, B. Reizis, and S. Jung. 2010. CX3CR1+ CD8a+ dendritic cells are a steady-state population related to plasmacytoid dendritic cells. Proc. Natl. Acad. Sci. USA 107: 14745-14750.
44. Petersen, T. R., D. A. Knight, C. W. Tang, T. L. Osmond, and I. F. Hermans. 2014. Batf3-independent langerin2 CX3CR12 CD8a+ splenic DCs represent a precursor for classical cross-presenting CD8a+ DCs. J. Leukoc. Biol. 96: 1001-1010.
45. Medema, J. P., D. H. Schuurhuis, D. Rea, J. van Tongeren, J. de Jong, S. A. Bres, S. Laban, R. E. Toes, M. Toebes, T. N. Schumacher, et al. 2001. Expression of the serpin serine protease inhibitor 6 protects dendritic cells from cytotoxic T lymphocyte-induced apoptosis: differential modulation by T helper type 1 and type 2 cells. J. Exp. Med. 194: 657-667.
46. Lovo, E., M. Zhang, L. Wang, and P. G. Ashton-Rickardt. 2012. Serine protease inhibitor 6 is required to protect dendritic cells from the kiss of death. J. Immunol. 188: 1057-1063.
47. Schiavoni, G., F. Mattei, and L. Gabriele. 2013. Type I interferons as stimulators of DC-mediated cross-priming: Impact on anti-tumor response. Front. Immunol. 4: 483.
48. Mattei, F., G. Schiavoni, F. Belardelli, and D. F. Tough. 2001. IL-15 is expressed by dendritic cells in response to type I IFN, double-stranded RNA, or lipopolysaccharide and promotes dendritic cell activation. J. Immunol. 167: 1179-1187.
49. Kolumam, G. A., S. Thomas, L. J. Thompson, J. Sprent, and K. Murali-Krishna. 2005. Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection. J. Exp. Med. 202: 637-650.
50. Ando, T., H. Ito, H. Ohtaki, and M. Seishima. 2013. Toll-like receptor agonists and alpha-galactosylceramide synergistically enhance the production of interferon-gamma in murine splenocytes. Sci Rep 3: 2559.
51. Zhang, J., A. Raper, N. Sugita, R. Hingorani, M. Salio, M. J. Palmowski, V. Cerundolo, and P. R. Crocker. 2006. Characterization of Siglec-H as a novel endocytic receptor expressed on murine plasmacytoid dendritic cell precursors. Blood 107: 3600-3608.
52. Tel, J., A. M. van der Leun, C. G. Figdor, R. Torensma, and I. J. de Vries. 2012. Harnessing human plasmacytoid dendritic cells as professional APCs. Cancer Immunol. Immunother. 61: 1279-1288.
53. Ballesteros-Tato, A., B. León, F. E. Lund, and T. D. Randall. 2010. Temporal changes in dendritic cell subsets, cross-priming and costimulation via CD70 control CD8(+) T cell responses to influenza. Nat. Immunol. 11: 216-224.
54. Kreutz, M., P. J. Tacken, and C. G. Figdor. 2013. Targeting dendritic cells-why bother? Blood 121: 2836-2844.
55. Idoyaga, J., A. Lubkin, C. Fiorese, M. H. Lahoud, I. Caminschi, Y. Huang, A. Rodriguez, B. E. Clausen, C. G. Park, C. Trumpfheller, and R. M. Steinman. 2011. Comparable T helper 1 (Th1) and CD8 T-cell immunity by targeting HIV gag p24 to CD8 dendritic cells within antibodies to Langerin, DEC205, and Clec9A. Proc. Natl. Acad. Sci. USA 108: 2384-2389.
56. Idoyaga, J., C. Cheong, K. Suda, N. Suda, J. Y. Kim, H. Lee, C. G. Park, and R. M. Steinman. 2008. Cutting edge: langerin/CD207 receptor on dendritic cells mediates efficient antigen presentation on MHC I and II products in vivo. J. Immunol. 180: 3647-3650.
57. Lahoud, M. H., F. Ahmet, S. Kitsoulis, S. S. Wan, D. Vremec, C.-N. Lee, B. Phipson, W. Shi, G. K. Smyth, A. M. Lew, et al. 2011. Targeting antigen to mouse dendritic cells via Clec9A induces potent CD4 T cell responses biased toward a follicular helper phenotype. J. Immunol. 187: 842-850.
58. Khan, S., M. S. Bijker, J. J. Weterings, H. J. Tanke, G. J. Adema, T. van Hall, J. W. Drijfhout, C. J. Melief, H. S. Overkleeft, G. A. van der Marel, et al. 2007. Distinct uptake mechanisms but similar intracellular processing of two different toll-like receptor ligand-peptide conjugates in dendritic cells. J. Biol. Chem. 282: 21145-21159.
59. Lahoud, M. H., F. Ahmet, J.-G. Zhang, S. Meuter, A. N. Policheni, S. Kitsoulis, C.-N. Lee, M. O'Keeffe, L. C. Sullivan, A. G. Brooks, et al. 2012. DEC-205 is a cell surface receptor for CpG oligonucleotides. Proc. Natl. Acad. Sci. USA 109: 16270-16275.
60. Oh, J. Z., J. S. Kurche, M. A. Burchill, and R. M. Kedl. 2011. TLR7 enables cross-presentation by multiple dendritic cell subsets through a type I IFNdependent pathway. Blood 118: 3028-3038.
61. Kjer-Nielsen, L., O. Patel, A. J. Corbett, J. Le Nours, B. Meehan, L. Liu, M. Bhati, Z. Chen, L. Kostenko, R. Reantragoon, et al. 2012. MR1 presents microbial vitamin B metabolites to MAIT cells. Nature 491: 717-723.
62. Kunzmann, V., E. Bauer, J. Feurle, F. Weissinger, H. P. Tony, and M. Wilhelm. 2000. Stimulation of gammadelta T cells by aminobisphosphonates and induction of antiplasma cell activity in multiple myeloma. Blood 96: 384-392.